The effect of compound Ma-ol-asal on treatment of the pediatric asthma
- Conditions
- Asthma.Asthma
- Registration Number
- IRCT2015083123834N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
patients with asthma aged 6-16 years old that referred to the pulmonary clinic of the Mofid Children's Hospital, Tehran, Iran; patients who are willing and consent to participate in the study.
Exclusion criteria: Patients under 6 and over 16 yearsold; patients with modprate asthma; patients with severe asthma; patients requiring hospitalization and patients who have attack; patients with underlying diseases such as CF, Bronchopulmonary dysplasia, heart failure, bronchotracheomalacia, GERD, bronchiectasis, Pulmonary embolism and sarcoidosis; patients who are taking medications such as aspirin, beta blocker and NSAID's; patients who become affected to other acute disease during the study; patients who are allergic to any components of compound Ma-ol-asal and request and patients who have decision to excluded from the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method